Company · NEOG
Neogen Corporation
Name as listed on its exchange; filed with the SEC as NEOGEN CORP.
Nasdaq's symbol directory lists NEOG on Nasdaq as “Neogen Corporation - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($10K); insiders sold on 1 occasion ($115K); 2 planned-sale notices; 3 company reports (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Yarwood Jeremy, Chief Scientific Officer sold $115K
- Nassif Mikheal, CEO bought $10K
Every trade (3)
- SELLYarwood Jeremy, Chief Scientific Officer sold $115K
- BUYNassif Mikheal, CEO bought $6K
- BUYNassif Mikheal, CEO bought $4K
Planned sales · SEC Form 144
Notice given
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice
- Yarwood Jeremy $115K
- Bernard Thierry $207K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Other events Nov 4, 2026
- Submission of matters to a vote of security holders Oct 7, 2026
- Results of operations and financial condition Oct 6, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.